(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000
Carl Zeiss Meditec-Dublin CoCe
Summary
This study will measure how well PathFinder 1.0 detects retinal abnormalities on macular cube OCT B-scans by assessing its sensitivity and specificity.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: 1. Able and willing to make the required study visits. 2. Able and willing to give written informed consent and follow study instructions. 3. Able and willing to complete ophthalmic imaging. 4. Adults 18 years of age or older. The subject population will be comprised of two groups (all categories below pertain to the central 6x6 mm macula area): Group A 1\. Subjects with absence of macular abnormalities Group B 1. Subjects with Disruption of the vitreoretinal interface (VRI) 2. Subjects with Intraretinal hyporeflective space (IRHS) 3. Subjects with Subretinal hyporefle…
Interventions
- DevicePathFinder 1.0 on CIRRUS HD-OCT
Participants undergo standard OCT imaging on CIRRUS HD-OCT systems, and the investigational PathFinder software analyzes the images for macular abnormalities without influencing clinical care.
Locations (6)
- Retina AssociatesTucson, Arizona
- Northern California Retina Vitreous AssociatesMountain View, California
- Premier Eyecare of San FranciscoSan Francisco, California
- Nova Southeastern University College of OptometryFort Lauderdale, Florida
- Eyecare Medical GroupPortland, Maine
- Moyes Eye CenterKansas City, Missouri